| KRX SM Exchange | PL Country |
BioMaxima S.A. is a distinguished entity based in Lublin, Poland, specializing in the manufacture and distribution of a vast array of microbiological media, reagents, and equipment for in vitro diagnostics. Founded in 1997, the company has exhibited a relentless commitment to advancing the diagnostic industry, catering to the needs of approximately 1,800 laboratories within its home country and extending its market reach to international territories. Through innovation and quality, BioMaxima S.A. has positioned itself as a key player in facilitating accurate and efficient diagnostic solutions for a myriad of medical conditions and applications.
These products are designed for testing biochemical parameters of blood and other body fluids. They play a critical role in diagnosing and monitoring a wide range of medical conditions, ensuring accurate results for healthcare providers.
Essential for combating antibiotic resistance, these systems facilitate the determination of microorganisms’ resistance to drugs, aiding in the prescribing of effective treatment options.
Offering rapid detection of infectious diseases, cancer markers, heart attack markers, and addictive substances, these tests are invaluable in emergency diagnostics and preventative health screenings.
These systems provide comprehensive analysis of urine, crucial for diagnosing kidney and urinary tract infections, diabetes, and other metabolic disorders.
Used for analyzing blood samples, these analyzers are pivotal in identifying and counting blood cells, aiding in the diagnosis of diseases like anemia, infections, and blood cancers.
These analyzers are key for measuring ion concentrations in blood samples, essential for identifying electrolyte imbalances and acid-base disorders.
Specialized in the detection of cardiac markers, these analyzers are crucial for the early diagnosis of myocardial infarction and other heart-related diseases.
Designed for healthcare settings, these devices provide accurate blood sugar readings, essential for diabetes management.
These devices assess blood gases and other critical blood parameters, instrumental in managing respiratory diseases, metabolic disorders, and critical care situations.
Includes a variety of products for microbiological analysis and molecular biology applications, such as surfaces and air controls, antibiotics discs, MIC strips, chromogenic and prepared culture media, microorganism storage systems, and media for inactivating and transporting samples.
Catering to the needs of veterinary medicine, these products help diagnose and manage diseases in animals, ensuring their health and well-being.
BioMaxima S.A. not only supplies products but also provides educational and training activities to ensure users can effectively utilize their products, enhancing the overall quality of diagnostics in various healthcare settings.